BioCurex, Inc.(fka BOCX)

[tommyb]

I am not suggesting anything as far as treatment or non-treatment. What happens after you are diagnosed with very early stage cancer is up to you, your doctor, your family, your financial resources, your current medical condition, your age, your insurance company, the various treatments available, etc. Which illustrates my point ... that that knowledge impacts a whole lot of things, and not necessarily in a good way. For example, if your doctor were to recommend that you irradiate various "suspect" parts of your body in the hope of killing off the (early) cancer, would you do it? What if the radiation could possibly cause more damage than the cancer, would you still do it? What if the various tests/procedures you might need to undergo to try and locate the cancer bankrupts your family, would you still do it?

My contention is that the medical community and the general population is not currently prepared to deal with the issue of "you have cancer, but we don't know what type, where it's located, or how fast it might spread". That limits the value of RECAF as a general screening test. When RECAF can be paired with a locator techniology or treatment technology, then it's value will skyrocket.